Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pocock, M. Ambrose, K. Ward, B. Chakrabarti, N. Duffy, J. O'Reilly, R. Parker, J. Cheney, R. Angus (Liverpool, United Kingdom). Evolving use of long-term NIV in COPD: Are we getting it right. Eur Respir J 2013; 42: Suppl. 57, 2475

Member's Comments

No comment yet.

Related content which might interest you: May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients? Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Telehealthcare in COPD – A feasibility trial Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Integrated care reduces hospital utilization among patients with severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Implementation of the patient outcomes and information service (POINTS) to improve the management of chronic obstructive pulmonary disease (COPD) in Lanarkshire Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Management of virtual COPD cases by pulmonary physicians Source: International Congress 2016 – COPD diagnosis and management Year: 2016 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Can we personalize COPD treatment by exacerbation frequency and severity? Three years of follow-up Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Is an interactive voice response system (IVRS) effective in contributing to avoiding unplanned admissions in chronic obstructive pulmonary disease (COPD) patients? Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015